HKG Epitherapeutics Limited

We are a startup research and development company that develops novel early DNA methylation markers in blood for detecting cancers.  Early detection of cancer can save many lives. Our technology is based on epigenetic principles.

Breakthrough High-Throughput Test for Early Detection of Hepatocellular Carcinoma Developed by HKG Epitherapeutics Ltd and Partners
international journal Nature com. (https://www.nature.com/articles/s41467-023-39055-7)